ESC 365 - Patient demographics in accessing clinical trials in cardiac transthyretin amyloidosis, a disparity of engagement for black patients..

Open Access

Patient demographics in accessing clinical trials in cardiac transthyretin amyloidosis, a disparity of engagement for black patients..

Session: Exploring precipitants of heart failure hospitalisation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mr J. Rickard (London, GB)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Mr James Rickard

Richmond Research Institute, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Frequency and time intervals of worsening heart failure events in relation to terminal cardiac endpoints in patients with heart failure

Speaker: Doctor K. Teramoto (Osaka, JP)

Genotype-driven prognostication in dilated cardiomyopathy

Speaker: Doctor D. Hong (Seoul, KR)

Non-obstructive coronary atherosclerosis increases risk of hospitalizations for heart failure

Speaker: Doctor J. Matejka (Pardubice, CZ)

Low self-care ability may be associated with an increased risk of adverse outcomes in patients with decompensated heart failure

Speaker: Doctor D. Kuanova (Aktobe, KZ)

Prognostic differences by sex in patients with de novo heart failure and reduced left ventricular ejection fraction. Insights from the COMFE Registry

Speaker: Mr O. Otero Garcia (Santiago de Compostela, ES)

Access the full session

Exploring precipitants of heart failure hospitalisation

Speakers: Mr J. Rickard, Doctor K. Teramoto, Doctor D. Hong, Doctor J. Matejka, Doctor D. Kuanova...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources